Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
Racism, xenophobia, and discrimination are important influences on health globally, but have so far been overlooked by health researchers, policymakers, and practitioners, finds new UCL-led research.
A new study has identified patterns in how common health conditions occur together in the same individuals, using data from four million patients in England.
Levels of a particular antibody in the blood could predict how well people with lupus respond to a new treatment approach, according to UCLH and UCL research.
A research team at the Royal National ENT and Eastman Dental Hospitals have won an award for their outstanding contribution to the NIHR portfolio of studies.
More research is needed to find the best ways of identifying the underlying causes and combatting the growing threat of antimicrobial resistance (AMR) around the world, according to a comment article published this week in The Lancet.